Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Lee Philina. Director active across 1 company, notably Blueprint Medicines Corp. In total, 9 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €626k. History available since 1 March 2023. The latest transaction was disclosed on 5 March 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
3,733 shares@ US$88.8049.1% of flowCommon StockSEC:0001415889-25-007396:0
11,000 shares0Common StockSEC:0001415889-25-006609:0
157 shares@ US$36.050.8% of flowCommon StockSEC:0001415889-24-020928:0
523 shares@ US$8.800.7% of flowCommon StockSEC:0001415889-24-008124:0
2,934 shares@ US$90.6938.4% of flowCommon StockSEC:0001415889-24-007559:0
12,500 shares0Common StockSEC:0001415889-24-007024:0
261 shares@ US$1.870.1% of flowCommon StockSEC:0001415889-24-003825:0
1,622 shares@ US$45.7211.0% of flowCommon StockSEC:0001415889-23-004562:0
12,500 shares0Common StockSEC:0001415889-23-004267:0